NIB reports healthy growth and outlook

Growth in its primary business has slowed, but further growth opportunities are being pursued.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Health insurance provider NIB Holdings (ASX: NHF) pleased investors on Monday when it reported another solid performance for the financial year, which saw a significant acquisition made in New Zealand as well as growth in its number of policyholders.

Although net profit after tax (NPAT) fell by 0.6% for the year to $67.2 million (this was affected by one-off costs), the group announced a 4.3% increase in pre-tax underwriting profit, which was driven by an impressive 14.8% increase in premium revenue to $1.3 billion. Earnings per share also improved to 15.3c compared to the previous year's earnings of 14.8c per share.

Despite tough market conditions – caused by claims inflation, constraints by government regulation regarding premium pricing, as well as recent policy changes – the group still recognised strong top-line growth, disciplined cost control, improved underlying profitability and expanded further into New Zealand, according to NIB's Managing Director, Mark Fitzgibbon.

Priorities

Whilst the group's Australian Resident Health Insurance (ARHI) business remains its top priority, the report could have weighed on investors a little with Fitzgibbon admitting that it will become more difficult to lift earnings whilst its growth prospects will be "more modest" at around 5% to 5.5%. The tough market conditions restricted ARHI's net underwriting profit to $59 million, which was 8.6% below the result in FY2012.

On the other hand, the company admitted that it had anticipated the slowed down growth and, as such, would continue to strive for growth in other areas such as international workers and students whilst also expanding further into New Zealand. Growth in these areas for the year were strong, whereby they contributed 20% of the total underwriting profit, compared to just 9% last year.

During the year, NIB also acquired TOWER Medical Insurance in New Zealand for $80.6 million, which it believes will provide the company with "an opportunity to emulate the success we have achieved in Australia in recent years through brand building, product design and outstanding customer service." The TOWER purchase also incurred one-off costs, including a $3.4 million acquisition cost.

Outlook

Currently, the company is forecasting consolidated operating profit for the next year to be in the range of $73 million and $80 million, in which it would need to defy claims inflation and changing policies to achieve. It believes that low interest rates, population growth and growing concerns regarding the public hospital system will aid it towards this profit goal.

Foolish takeaway

Although growth in its priority business is slowing, NIB's strong management team will continue to guide the company towards other strategic investments. As such, the company maintains fantastic growth opportunities, which should help investors recognise significant returns in the long run. Currently priced at $2.12 per share, the group also offers an attractive 4.7% dividend yield.

Are you interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Ryan Newman owns shares in NIB Holdings.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »